Kate Broderick: INO-4800 – A DNA based vaccine against COVID-19

A DNA based vaccine against COVIDПодробнее

Advantages of DNA Vaccines in Response to the COVID-19 OutbreakПодробнее

INOVIO's Dr. Kate Broderick Interview on Fox NewsПодробнее

Kate Broderick, Ph.D.Подробнее

Inovio Senior Vice President Kate Broderick; first vaccine for coronavirus COVID-19 CBS 60 minutesПодробнее

Kate E. Broderick| Inovio Pharmaceuticals| USA | Vaccines 2014 | OMICS InternationalПодробнее

COVID-19 Webinar on DNA vaccines --- Sponsored by Sino BiologicalПодробнее

First Congress, 2-Scientific Session One Part 1Подробнее

Kate Broderick, Inovio: 2-3 hours to design a Covid-19 VaccineПодробнее

Bill Gates funded vaccine INO-4800 for COVID19|DNA VACCINE FOR COVID-19|COVID19Подробнее

COVID-19 Vaccines: Your Questions AnsweredПодробнее

In-Depth: Inovio COVID-19 vaccine's futureПодробнее

INOVIO DNA Medicine MOAПодробнее

Inovio Pharmaceuticals Aims To Have More Than 1 Million COVID19 Vaccines By End Of YearПодробнее

How a Covid-19 Vaccine Human Trial WorksПодробнее

San Diego Lab’s Potential DNA-Based Coronavirus Vaccine for COVID-19Подробнее

INO-4800 vaccine starts clinical trials in S. Korea -- WHO expert explains how it worksПодробнее

Inovio's COVID-19 Vaccine Set To Go Through Critical Stage Three TrialПодробнее

INOVIO Pharmaceuticals initiates phase one human clinical trial for COVID-19 vaccineПодробнее